ACR	B:C1515941
Appropriateness	O
Criteria	O
(	O
®)	O
Radiologic	O
Management	O
of	O
Mesenteric	O
Ischemia	I:C1412000
Mesenteric	O
vascular	I:C1412000
insufficiency	I:C1412000
is	O
a	O
serious	O
medical	O
condition	O
that	O
may	O
lead	O
to	O
bowel	O
infarction	I:C0241950
,	O
morbidity	O
,	O
and	O
mortality	O
that	O
may	O
approach	O
50	O
%	O
.	O

ACR	O
Appropriateness	O
Criteria	O
(	O
®)	O
Radiologic	O
Management	B:C0376636
of	O
Mesenteric	O
Ischemia	I:C1412000
Mesenteric	O
vascular	I:C1412000
insufficiency	I:C1412000
is	O
a	O
serious	O
medical	O
condition	O
that	O
may	O
lead	O
to	O
bowel	O
infarction	I:C0241950
,	O
morbidity	O
,	O
and	O
mortality	O
that	O
may	O
approach	O
50	O
%	O
.	O

ACR	O
Appropriateness	O
Criteria	O
(	O
®)	O
Radiologic	O
Management	O
of	O
Mesenteric	B:C1412000
Ischemia	I:C1412000
Mesenteric	O
vascular	I:C1412000
insufficiency	I:C1412000
is	O
a	O
serious	O
medical	O
condition	O
that	O
may	O
lead	O
to	O
bowel	O
infarction	I:C0241950
,	O
morbidity	O
,	O
and	O
mortality	O
that	O
may	O
approach	O
50	O
%	O
.	O

ACR	O
Appropriateness	O
Criteria	O
(	O
®)	O
Radiologic	O
Management	O
of	O
Mesenteric	O
Ischemia	I:C1412000
Mesenteric	B:C1412000
vascular	I:C1412000
insufficiency	I:C1412000
is	O
a	O
serious	O
medical	O
condition	O
that	O
may	O
lead	O
to	O
bowel	O
infarction	I:C0241950
,	O
morbidity	O
,	O
and	O
mortality	O
that	O
may	O
approach	O
50	O
%	O
.	O

ACR	O
Appropriateness	O
Criteria	O
(	O
®)	O
Radiologic	O
Management	O
of	O
Mesenteric	O
Ischemia	I:C1412000
Mesenteric	O
vascular	I:C1412000
insufficiency	I:C1412000
is	O
a	O
serious	O
medical	O
condition	O
that	O
may	O
lead	O
to	O
bowel	B:C0241950
infarction	I:C0241950
,	O
morbidity	O
,	O
and	O
mortality	O
that	O
may	O
approach	O
50	O
%	O
.	O

ACR	O
Appropriateness	O
Criteria	O
(	O
®)	O
Radiologic	O
Management	O
of	O
Mesenteric	O
Ischemia	I:C1412000
Mesenteric	O
vascular	I:C1412000
insufficiency	I:C1412000
is	O
a	O
serious	O
medical	O
condition	O
that	O
may	O
lead	O
to	O
bowel	O
infarction	I:C0241950
,	O
morbidity	O
,	O
and	O
mortality	O
that	O
may	O
approach	B:C0449445
50	O
%	O
.	O

Recommended	O
therapy	B:C0087111
for	O
acute	O
mesenteric	I:C0001363
ischemia	I:C0001363
includes	O
aspiration	O
embolectomy	O
,	O
transcatheter	O
thrombolysis	O
,	O
and	O
angioplasty	O
with	O
or	O
without	O
stenting	O
for	O
the	O
treatment	O
of	O
underlying	O
arterial	O
stenosis	I:C0238397
.	O

Recommended	O
therapy	O
for	O
acute	B:C0001363
mesenteric	I:C0001363
ischemia	I:C0001363
includes	O
aspiration	O
embolectomy	O
,	O
transcatheter	O
thrombolysis	O
,	O
and	O
angioplasty	O
with	O
or	O
without	O
stenting	O
for	O
the	O
treatment	O
of	O
underlying	O
arterial	O
stenosis	I:C0238397
.	O

Recommended	O
therapy	O
for	O
acute	O
mesenteric	I:C0001363
ischemia	I:C0001363
includes	O
aspiration	B:C0349707
embolectomy	O
,	O
transcatheter	O
thrombolysis	O
,	O
and	O
angioplasty	O
with	O
or	O
without	O
stenting	O
for	O
the	O
treatment	O
of	O
underlying	O
arterial	O
stenosis	I:C0238397
.	O

Recommended	O
therapy	O
for	O
acute	O
mesenteric	I:C0001363
ischemia	I:C0001363
includes	O
aspiration	O
embolectomy	B:C0162575
,	O
transcatheter	O
thrombolysis	O
,	O
and	O
angioplasty	O
with	O
or	O
without	O
stenting	O
for	O
the	O
treatment	O
of	O
underlying	O
arterial	O
stenosis	I:C0238397
.	O

Recommended	O
therapy	O
for	O
acute	O
mesenteric	I:C0001363
ischemia	I:C0001363
includes	O
aspiration	O
embolectomy	O
,	O
transcatheter	B:C0203005
thrombolysis	O
,	O
and	O
angioplasty	O
with	O
or	O
without	O
stenting	O
for	O
the	O
treatment	O
of	O
underlying	O
arterial	O
stenosis	I:C0238397
.	O

Recommended	O
therapy	O
for	O
acute	O
mesenteric	I:C0001363
ischemia	I:C0001363
includes	O
aspiration	O
embolectomy	O
,	O
transcatheter	O
thrombolysis	B:C0040044
,	O
and	O
angioplasty	O
with	O
or	O
without	O
stenting	O
for	O
the	O
treatment	O
of	O
underlying	O
arterial	O
stenosis	I:C0238397
.	O

Recommended	O
therapy	O
for	O
acute	O
mesenteric	I:C0001363
ischemia	I:C0001363
includes	O
aspiration	O
embolectomy	O
,	O
transcatheter	O
thrombolysis	O
,	O
and	O
angioplasty	B:C0162577
with	O
or	O
without	O
stenting	O
for	O
the	O
treatment	O
of	O
underlying	O
arterial	O
stenosis	I:C0238397
.	O

Recommended	O
therapy	O
for	O
acute	O
mesenteric	I:C0001363
ischemia	I:C0001363
includes	O
aspiration	O
embolectomy	O
,	O
transcatheter	O
thrombolysis	O
,	O
and	O
angioplasty	O
with	O
or	O
without	O
stenting	B:C2348535
for	O
the	O
treatment	O
of	O
underlying	O
arterial	O
stenosis	I:C0238397
.	O

Recommended	O
therapy	O
for	O
acute	O
mesenteric	I:C0001363
ischemia	I:C0001363
includes	O
aspiration	O
embolectomy	O
,	O
transcatheter	O
thrombolysis	O
,	O
and	O
angioplasty	O
with	O
or	O
without	O
stenting	O
for	O
the	O
treatment	B:C0087111
of	O
underlying	O
arterial	O
stenosis	I:C0238397
.	O

Recommended	O
therapy	O
for	O
acute	O
mesenteric	I:C0001363
ischemia	I:C0001363
includes	O
aspiration	O
embolectomy	O
,	O
transcatheter	O
thrombolysis	O
,	O
and	O
angioplasty	O
with	O
or	O
without	O
stenting	O
for	O
the	O
treatment	O
of	O
underlying	O
arterial	B:C0238397
stenosis	I:C0238397
.	O

Nonocclusive	B:C3852986
mesenteric	I:C3852986
ischemia	I:C3852986
may	O
respond	O
to	O
transarterial	O
infusion	I:C0021439
of	O
vasodilators	O
such	O
as	O
nitroglycerin	O
,	O
papaverine	O
,	O
glucagon	O
,	O
and	O
prostaglandin	O
E1	I:C0002335
.	O

Nonocclusive	O
mesenteric	I:C3852986
ischemia	I:C3852986
may	O
respond	O
to	O
transarterial	B:C0021439
infusion	I:C0021439
of	O
vasodilators	O
such	O
as	O
nitroglycerin	O
,	O
papaverine	O
,	O
glucagon	O
,	O
and	O
prostaglandin	O
E1	I:C0002335
.	O

Nonocclusive	O
mesenteric	I:C3852986
ischemia	I:C3852986
may	O
respond	O
to	O
transarterial	O
infusion	I:C0021439
of	O
vasodilators	B:C0042402
such	O
as	O
nitroglycerin	O
,	O
papaverine	O
,	O
glucagon	O
,	O
and	O
prostaglandin	O
E1	I:C0002335
.	O

Nonocclusive	O
mesenteric	I:C3852986
ischemia	I:C3852986
may	O
respond	O
to	O
transarterial	O
infusion	I:C0021439
of	O
vasodilators	O
such	O
as	O
nitroglycerin	B:C0017887
,	O
papaverine	O
,	O
glucagon	O
,	O
and	O
prostaglandin	O
E1	I:C0002335
.	O

Nonocclusive	O
mesenteric	I:C3852986
ischemia	I:C3852986
may	O
respond	O
to	O
transarterial	O
infusion	I:C0021439
of	O
vasodilators	O
such	O
as	O
nitroglycerin	O
,	O
papaverine	B:C0030350
,	O
glucagon	O
,	O
and	O
prostaglandin	O
E1	I:C0002335
.	O

Nonocclusive	O
mesenteric	I:C3852986
ischemia	I:C3852986
may	O
respond	O
to	O
transarterial	O
infusion	I:C0021439
of	O
vasodilators	O
such	O
as	O
nitroglycerin	O
,	O
papaverine	O
,	O
glucagon	B:C0017687
,	O
and	O
prostaglandin	O
E1	I:C0002335
.	O

Nonocclusive	O
mesenteric	I:C3852986
ischemia	I:C3852986
may	O
respond	O
to	O
transarterial	O
infusion	I:C0021439
of	O
vasodilators	O
such	O
as	O
nitroglycerin	O
,	O
papaverine	O
,	O
glucagon	O
,	O
and	O
prostaglandin	B:C0002335
E1	I:C0002335
.	O

Recommended	O
therapy	B:C0087111
for	O
chronic	O
mesenteric	I:C0311262
ischemia	I:C0311262
includes	O
angioplasty	O
with	O
or	O
without	O
stent	O
placement	I:C0522776
and	O
,	O
if	O
an	O
endovascular	O
approach	I:C1997114
is	O
not	O
possible	O
,	O
surgical	O
bypass	I:C1536078
or	O
endarterectomy	O
.	O

Recommended	O
therapy	O
for	O
chronic	B:C0311262
mesenteric	I:C0311262
ischemia	I:C0311262
includes	O
angioplasty	O
with	O
or	O
without	O
stent	O
placement	I:C0522776
and	O
,	O
if	O
an	O
endovascular	O
approach	I:C1997114
is	O
not	O
possible	O
,	O
surgical	O
bypass	I:C1536078
or	O
endarterectomy	O
.	O

Recommended	O
therapy	O
for	O
chronic	O
mesenteric	I:C0311262
ischemia	I:C0311262
includes	O
angioplasty	B:C0162577
with	O
or	O
without	O
stent	O
placement	I:C0522776
and	O
,	O
if	O
an	O
endovascular	O
approach	I:C1997114
is	O
not	O
possible	O
,	O
surgical	O
bypass	I:C1536078
or	O
endarterectomy	O
.	O

Recommended	O
therapy	O
for	O
chronic	O
mesenteric	I:C0311262
ischemia	I:C0311262
includes	O
angioplasty	O
with	O
or	O
without	O
stent	B:C0522776
placement	I:C0522776
and	O
,	O
if	O
an	O
endovascular	O
approach	I:C1997114
is	O
not	O
possible	O
,	O
surgical	O
bypass	I:C1536078
or	O
endarterectomy	O
.	O

Recommended	O
therapy	O
for	O
chronic	O
mesenteric	I:C0311262
ischemia	I:C0311262
includes	O
angioplasty	O
with	O
or	O
without	O
stent	O
placement	I:C0522776
and	O
,	O
if	O
an	O
endovascular	B:C1997114
approach	I:C1997114
is	O
not	O
possible	O
,	O
surgical	O
bypass	I:C1536078
or	O
endarterectomy	O
.	O

Recommended	O
therapy	O
for	O
chronic	O
mesenteric	I:C0311262
ischemia	I:C0311262
includes	O
angioplasty	O
with	O
or	O
without	O
stent	O
placement	I:C0522776
and	O
,	O
if	O
an	O
endovascular	O
approach	I:C1997114
is	O
not	O
possible	O
,	O
surgical	B:C1536078
bypass	I:C1536078
or	O
endarterectomy	O
.	O

Recommended	O
therapy	O
for	O
chronic	O
mesenteric	I:C0311262
ischemia	I:C0311262
includes	O
angioplasty	O
with	O
or	O
without	O
stent	O
placement	I:C0522776
and	O
,	O
if	O
an	O
endovascular	O
approach	I:C1997114
is	O
not	O
possible	O
,	O
surgical	O
bypass	I:C1536078
or	O
endarterectomy	B:C0014098
.	O

The	O
diagnosis	B:C0011900
of	O
median	O
arcuate	I:C1861783
ligament	I:C1861783
syndrome	I:C1861783
is	O
controversial	O
,	O
but	O
surgical	O
release	O
may	O
be	O
appropriate	O
depending	O
on	O
the	O
clinical	O
situation	O
.	O

The	O
diagnosis	O
of	O
median	B:C1861783
arcuate	I:C1861783
ligament	I:C1861783
syndrome	I:C1861783
is	O
controversial	O
,	O
but	O
surgical	O
release	O
may	O
be	O
appropriate	O
depending	O
on	O
the	O
clinical	O
situation	O
.	O

The	O
diagnosis	O
of	O
median	O
arcuate	I:C1861783
ligament	I:C1861783
syndrome	I:C1861783
is	O
controversial	O
,	O
but	O
surgical	B:C0543467
release	O
may	O
be	O
appropriate	O
depending	O
on	O
the	O
clinical	O
situation	O
.	O

Venous	B:C0348013
mesenteric	O
ischemia	I:C1412000
may	O
respond	O
to	O
systemic	O
anticoagulation	O
alone	O
.	O

Venous	O
mesenteric	B:C1412000
ischemia	I:C1412000
may	O
respond	O
to	O
systemic	O
anticoagulation	O
alone	O
.	O

Venous	O
mesenteric	O
ischemia	I:C1412000
may	O
respond	O
to	O
systemic	O
anticoagulation	B:C0003281
alone	O
.	O

Transhepatic	B:C0589464
or	O
transjugular	O
superior	O
mesenteric	I:C0226742
vein	I:C0226742
catheterization	O
and	O
thrombolytic	O
infusion	O
can	O
be	O
offered	O
depending	O
on	O
the	O
severity	O
of	O
symptoms	O
,	O
condition	O
of	I:C0683521
the	I:C0683521
patient	I:C0683521
,	O
and	O
response	O
to	O
systemic	O
anticoagulation	O
.	O

Transhepatic	O
or	O
transjugular	O
superior	B:C0226742
mesenteric	I:C0226742
vein	I:C0226742
catheterization	O
and	O
thrombolytic	O
infusion	O
can	O
be	O
offered	O
depending	O
on	O
the	O
severity	O
of	O
symptoms	O
,	O
condition	O
of	I:C0683521
the	I:C0683521
patient	I:C0683521
,	O
and	O
response	O
to	O
systemic	O
anticoagulation	O
.	O

Transhepatic	O
or	O
transjugular	O
superior	O
mesenteric	I:C0226742
vein	I:C0226742
catheterization	O
and	O
thrombolytic	O
infusion	O
can	O
be	O
offered	O
depending	O
on	O
the	O
severity	O
of	O
symptoms	B:C1457887
,	O
condition	O
of	I:C0683521
the	I:C0683521
patient	I:C0683521
,	O
and	O
response	O
to	O
systemic	O
anticoagulation	O
.	O

Transhepatic	O
or	O
transjugular	O
superior	O
mesenteric	I:C0226742
vein	I:C0226742
catheterization	O
and	O
thrombolytic	O
infusion	O
can	O
be	O
offered	O
depending	O
on	O
the	O
severity	O
of	O
symptoms	O
,	O
condition	B:C0683521
of	I:C0683521
the	I:C0683521
patient	I:C0683521
,	O
and	O
response	O
to	O
systemic	O
anticoagulation	O
.	O

Transhepatic	O
or	O
transjugular	O
superior	O
mesenteric	I:C0226742
vein	I:C0226742
catheterization	O
and	O
thrombolytic	O
infusion	O
can	O
be	O
offered	O
depending	O
on	O
the	O
severity	O
of	O
symptoms	O
,	O
condition	O
of	I:C0683521
the	I:C0683521
patient	I:C0683521
,	O
and	O
response	O
to	O
systemic	O
anticoagulation	B:C0003281
.	O

Adjunct	O
transjugular	B:C0339897
intrahepatic	I:C0339897
portosystemic	I:C0339897
shunt	I:C0339897
creation	I:C0339897
can	O
be	O
considered	O
for	O
outflow	O
improvement	O
.	O

The	O
American	B:C1515941
College	I:C1515941
of	I:C1515941
Radiology	I:C1515941
Appropriateness	O
Criteria	O
are	O
evidence	O
-	O
based	O
guidelines	O
for	O
specific	O
clinical	O
conditions	I:C0683521
that	O
are	O
reviewed	O
annually	O
by	O
a	O
multidisciplinary	O
expert	I:C1319406
panel	I:C1319406
.	O

The	O
American	O
College	I:C1515941
of	I:C1515941
Radiology	I:C1515941
Appropriateness	O
Criteria	O
are	O
evidence	O
-	O
based	O
guidelines	B:C0162791
for	O
specific	O
clinical	O
conditions	I:C0683521
that	O
are	O
reviewed	O
annually	O
by	O
a	O
multidisciplinary	O
expert	I:C1319406
panel	I:C1319406
.	O

The	O
American	O
College	I:C1515941
of	I:C1515941
Radiology	I:C1515941
Appropriateness	O
Criteria	O
are	O
evidence	O
-	O
based	O
guidelines	O
for	O
specific	O
clinical	B:C0683521
conditions	I:C0683521
that	O
are	O
reviewed	O
annually	O
by	O
a	O
multidisciplinary	O
expert	I:C1319406
panel	I:C1319406
.	O

The	O
American	O
College	I:C1515941
of	I:C1515941
Radiology	I:C1515941
Appropriateness	O
Criteria	O
are	O
evidence	O
-	O
based	O
guidelines	O
for	O
specific	O
clinical	O
conditions	I:C0683521
that	O
are	O
reviewed	O
annually	O
by	O
a	O
multidisciplinary	B:C1319406
expert	I:C1319406
panel	I:C1319406
.	O

The	O
guideline	B:C0162791
development	O
and	O
revision	O
include	O
an	O
extensive	O
analysis	I:C0936012
of	O
current	O
medical	O
literature	O
from	O
peer	O
-	I:C2985503
reviewed	I:C2985503
journals	I:C2985503
and	O
the	O
application	O
of	O
well	O
-	O
established	O
methodologies	O
(	O
RAND	O
/	O
UCLA	O
Appropriateness	O
Method	O
and	O
Grading	O
of	I:C0282574
Recommendations	I:C0282574
Assessment	I:C0282574
,	I:C0282574
Development	I:C0282574
,	I:C0282574
and	I:C0282574
Evaluation	I:C0282574
or	O
GRADE	O
)	O
to	O
rate	O
the	O
appropriateness	O
of	O
imaging	O
and	O
treatment	O
procedures	I:C0087111
for	O
specific	O
clinical	O
scenarios	O
.	O

The	O
guideline	O
development	O
and	O
revision	O
include	O
an	O
extensive	B:C0936012
analysis	I:C0936012
of	O
current	O
medical	O
literature	O
from	O
peer	O
-	I:C2985503
reviewed	I:C2985503
journals	I:C2985503
and	O
the	O
application	O
of	O
well	O
-	O
established	O
methodologies	O
(	O
RAND	O
/	O
UCLA	O
Appropriateness	O
Method	O
and	O
Grading	O
of	I:C0282574
Recommendations	I:C0282574
Assessment	I:C0282574
,	I:C0282574
Development	I:C0282574
,	I:C0282574
and	I:C0282574
Evaluation	I:C0282574
or	O
GRADE	O
)	O
to	O
rate	O
the	O
appropriateness	O
of	O
imaging	O
and	O
treatment	O
procedures	I:C0087111
for	O
specific	O
clinical	O
scenarios	O
.	O

The	O
guideline	O
development	O
and	O
revision	O
include	O
an	O
extensive	O
analysis	I:C0936012
of	O
current	O
medical	O
literature	O
from	O
peer	B:C2985503
-	I:C2985503
reviewed	I:C2985503
journals	I:C2985503
and	O
the	O
application	O
of	O
well	O
-	O
established	O
methodologies	O
(	O
RAND	O
/	O
UCLA	O
Appropriateness	O
Method	O
and	O
Grading	O
of	I:C0282574
Recommendations	I:C0282574
Assessment	I:C0282574
,	I:C0282574
Development	I:C0282574
,	I:C0282574
and	I:C0282574
Evaluation	I:C0282574
or	O
GRADE	O
)	O
to	O
rate	O
the	O
appropriateness	O
of	O
imaging	O
and	O
treatment	O
procedures	I:C0087111
for	O
specific	O
clinical	O
scenarios	O
.	O

The	O
guideline	O
development	O
and	O
revision	O
include	O
an	O
extensive	O
analysis	I:C0936012
of	O
current	O
medical	O
literature	O
from	O
peer	O
-	I:C2985503
reviewed	I:C2985503
journals	I:C2985503
and	O
the	O
application	O
of	O
well	O
-	O
established	O
methodologies	B:C0086912
(	O
RAND	O
/	O
UCLA	O
Appropriateness	O
Method	O
and	O
Grading	O
of	I:C0282574
Recommendations	I:C0282574
Assessment	I:C0282574
,	I:C0282574
Development	I:C0282574
,	I:C0282574
and	I:C0282574
Evaluation	I:C0282574
or	O
GRADE	O
)	O
to	O
rate	O
the	O
appropriateness	O
of	O
imaging	O
and	O
treatment	O
procedures	I:C0087111
for	O
specific	O
clinical	O
scenarios	O
.	O

The	O
guideline	O
development	O
and	O
revision	O
include	O
an	O
extensive	O
analysis	I:C0936012
of	O
current	O
medical	O
literature	O
from	O
peer	O
-	I:C2985503
reviewed	I:C2985503
journals	I:C2985503
and	O
the	O
application	O
of	O
well	O
-	O
established	O
methodologies	O
(	O
RAND	B:C3826892
/	O
UCLA	O
Appropriateness	O
Method	O
and	O
Grading	O
of	I:C0282574
Recommendations	I:C0282574
Assessment	I:C0282574
,	I:C0282574
Development	I:C0282574
,	I:C0282574
and	I:C0282574
Evaluation	I:C0282574
or	O
GRADE	O
)	O
to	O
rate	O
the	O
appropriateness	O
of	O
imaging	O
and	O
treatment	O
procedures	I:C0087111
for	O
specific	O
clinical	O
scenarios	O
.	O

The	O
guideline	O
development	O
and	O
revision	O
include	O
an	O
extensive	O
analysis	I:C0936012
of	O
current	O
medical	O
literature	O
from	O
peer	O
-	I:C2985503
reviewed	I:C2985503
journals	I:C2985503
and	O
the	O
application	O
of	O
well	O
-	O
established	O
methodologies	O
(	O
RAND	O
/	O
UCLA	O
Appropriateness	O
Method	O
and	O
Grading	B:C0282574
of	I:C0282574
Recommendations	I:C0282574
Assessment	I:C0282574
,	I:C0282574
Development	I:C0282574
,	I:C0282574
and	I:C0282574
Evaluation	I:C0282574
or	O
GRADE	O
)	O
to	O
rate	O
the	O
appropriateness	O
of	O
imaging	O
and	O
treatment	O
procedures	I:C0087111
for	O
specific	O
clinical	O
scenarios	O
.	O

The	O
guideline	O
development	O
and	O
revision	O
include	O
an	O
extensive	O
analysis	I:C0936012
of	O
current	O
medical	O
literature	O
from	O
peer	O
-	I:C2985503
reviewed	I:C2985503
journals	I:C2985503
and	O
the	O
application	O
of	O
well	O
-	O
established	O
methodologies	O
(	O
RAND	O
/	O
UCLA	O
Appropriateness	O
Method	O
and	O
Grading	O
of	I:C0282574
Recommendations	I:C0282574
Assessment	I:C0282574
,	I:C0282574
Development	I:C0282574
,	I:C0282574
and	I:C0282574
Evaluation	I:C0282574
or	O
GRADE	B:C0282574
)	O
to	O
rate	O
the	O
appropriateness	O
of	O
imaging	O
and	O
treatment	O
procedures	I:C0087111
for	O
specific	O
clinical	O
scenarios	O
.	O

The	O
guideline	O
development	O
and	O
revision	O
include	O
an	O
extensive	O
analysis	I:C0936012
of	O
current	O
medical	O
literature	O
from	O
peer	O
-	I:C2985503
reviewed	I:C2985503
journals	I:C2985503
and	O
the	O
application	O
of	O
well	O
-	O
established	O
methodologies	O
(	O
RAND	O
/	O
UCLA	O
Appropriateness	O
Method	O
and	O
Grading	O
of	I:C0282574
Recommendations	I:C0282574
Assessment	I:C0282574
,	I:C0282574
Development	I:C0282574
,	I:C0282574
and	I:C0282574
Evaluation	I:C0282574
or	O
GRADE	O
)	O
to	O
rate	O
the	O
appropriateness	O
of	O
imaging	B:C0079595
and	O
treatment	O
procedures	I:C0087111
for	O
specific	O
clinical	O
scenarios	O
.	O

The	O
guideline	O
development	O
and	O
revision	O
include	O
an	O
extensive	O
analysis	I:C0936012
of	O
current	O
medical	O
literature	O
from	O
peer	O
-	I:C2985503
reviewed	I:C2985503
journals	I:C2985503
and	O
the	O
application	O
of	O
well	O
-	O
established	O
methodologies	O
(	O
RAND	O
/	O
UCLA	O
Appropriateness	O
Method	O
and	O
Grading	O
of	I:C0282574
Recommendations	I:C0282574
Assessment	I:C0282574
,	I:C0282574
Development	I:C0282574
,	I:C0282574
and	I:C0282574
Evaluation	I:C0282574
or	O
GRADE	O
)	O
to	O
rate	O
the	O
appropriateness	O
of	O
imaging	O
and	O
treatment	B:C0087111
procedures	I:C0087111
for	O
specific	O
clinical	O
scenarios	O
.	O

In	O
those	O
instances	O
where	O
evidence	O
is	O
lacking	O
or	O
equivocal	O
,	O
expert	O
opinion	O
may	O
supplement	O
the	O
available	O
evidence	O
to	O
recommend	O
imaging	B:C0079595
or	O
treatment	O
.	O

In	O
those	O
instances	O
where	O
evidence	O
is	O
lacking	O
or	O
equivocal	O
,	O
expert	O
opinion	O
may	O
supplement	O
the	O
available	O
evidence	O
to	O
recommend	O
imaging	O
or	O
treatment	B:C0087111
.	O

